Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 1, 2000, Pages 295-298

  Kim, Kyung Soo ^a   Kumar, Sandeep ^a   Simmons, William H ^b   Brown, Nancy J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE P; APSTATIN; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR; QUINAPRIL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; URTICARIA;

ADULT; AMINOPEPTIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; HUMANS; INFLAMMATION; ISOQUINOLINES; MALE; PEPTIDES; PROTEASE INHIBITORS; TETRAHYDROISOQUINOLINES; TIME FACTORS; URTICARIA;

EID: 0033962498     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brown NJ and Vaughan DE (1998) Angiotensin-converting enzyme inhibitors. Circulation 97:1411-1420.
2. Damas J, Liegeois JF and Simmons WH (1996) Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and amino-peptidase P in rat paws. Naunyn-Schmiedeberg's Arch Pharmacol 354:670-676.
3. 9] BK: Influence of enalaprilat. Am J Physiol 96:H1340-H1347.
4. Ersahin C, Euler DE and Simmons WH (1999) Cardioprotective effects of the aminopeptidase P inhibitor apstatin: Studies on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol, in press.
5. Ersahin C and Simmons WH (1997) Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation. J Cardiovasc Pharmacol 30:96-101.
6. Ferner RE, Wilson D, Paterson J, Wilinson R and Rawlins MD (1989) The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients. Br J Clin Pharmacol 27:337-342.
7. Holtzman EJ, Pillay G, Rosenthal T and Yaron A (1987) Aminopeptidase P activity in rat organs and human serum. Anal Biochem 162:476-484.
8. Ishida H, Scicli AG and Carretero OA (1989) Role of angiotensin converting enzyme and other peptidases in vivo metabolism of kinins. Hypertension 14:322-327.
9. Kitamura S, Carbini LA, Carretero OA, Simmons WH and Scicli AG (1995) Potentiation by aminopeptidase P of blood pressure response to bradykinin. Br J Pharmacol 114:6-7.
10. Kitamura S, Carbini LA, Simmons WH and Scicli AG (1999) Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses. Am J Physiol 276: H1664-H1671.
11. Lasch J, Moschner S, Sann H, Zellmer S and Koelech R (1998) Aminopeptidase P - a cell-surface antigen of endothelial and lymphoid cells: catalytic and immunohistotopical evidences. Biol Chem 379:705-709.
12. McAlpine LG and Thomson NC (1989) The effect of indomethacin and enalapril on the cutaneous response to bradykinin. Br J Clin Pharmacol 27:870-872.
13. Olson SC, Horvath AM, Michniewicz BM, Sedman AJ, Colburn WA and Welling PG (1989) The clinical pharmacokinetics of quinapril. Angiology 40:351-359.
14. Prechel MM, Orawski AT, Maggiora LL and Simmons WH (1995) Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung. J Pharmacol Exp Ther 275:1136-1142.
15. Rusu I and Yaron A (1992) Aminopeptidase P from human leukocytes. Eur J Biochen 210:93-100.
16. Ryan JW, Berryer P, Chung AY and Sheffy DH (1994) Characterization of rat pulmonary vascular aminopeptidase P in vivo: Role in the inactivation of bradykinin. J Pharmacol Exp Ther 269:941-947.
17. Ryan JW, Papapetropoulos A, Ju H, Denslow ND, Antonov A, Virmani R, Kolodgie FD, Gerrity RG and Catravas JD (1996) Aminopeptidase P is disposed on human endothelial cells. Immunopharmacology 32:149-152.
18. Ryan JW, Roblero J and Stewart JM (1968) Inactivation of bradykinin in the pulmonary circulation. Biochem J 110:795-797.
19. Sheikh IA and Kaplan AP (1989) The mechanism of degradation of bradykinin (lysyl-bradykinin) in human serum. Adv Exp Med Biol 247A:331-336.
20. Vanhoof G, De Meester I, Goossens F, Hendriks D, Scharpe S and Yaron A (1992) Kininase activity in human platelets: Cleavage of the Arg1-Pro2 bond of bradykinin by aminopeptidase P. Biochem Pharmacol 44:479-487.
21. Vanhoutte PM (1989) Endothelium and control of vascular function: State of the art lecture. Hypertension 13:658-667.
22. Venema RC, Ju H, Zou R, Venema VJ and Ryan JW (1997) Cloning and tissue distribution of human membrane-bound aminopeptidase P. Biochim Biophys Acta 1354:45-48.
23. Yaron A and Naider F (1993) Proline-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 28:31-81.
24. Yoshimoto T, Orawski AT and Simmons WH (1994) Substrate specificity of aminopeptidase P from Escherichia coli: Comparison with membrane-bound forms from rat and bovine lung. Arch Biochem Biophys 311:28-34.